HER-2 POSITIVE BREAST CANCER
Clinical trials for HER-2 POSITIVE BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new HER-2 POSITIVE BREAST CANCER trials appear
Sign up with your email to follow new studies for HER-2 POSITIVE BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising combo aims to stall advanced breast cancer
Disease control OngoingThis study tests whether adding the drug palbociclib to standard hormone and anti-HER2 therapy can help people with a specific type of advanced breast cancer (HR+/HER2+) live longer without their cancer growing. About 518 adults with metastatic breast cancer that cannot be surgic…
Matched conditions: HER-2 POSITIVE BREAST CANCER
Phase: PHASE3 • Sponsor: Alliance Foundation Trials, LLC. • Aim: Disease control
Last updated May 26, 2026 05:06 UTC
-
New drug combo shows promise in shrinking aggressive breast tumors before surgery
Disease control OngoingThis study tests two targeted drugs, T-DM1 and pertuzumab, given before surgery to people with early-stage HER2-positive breast cancer. The goal is to see if this combination can completely eliminate cancer cells in the breast, potentially reducing the need for more aggressive tr…
Matched conditions: HER-2 POSITIVE BREAST CANCER
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
New drug combo shows promise for Hard-to-Treat breast cancer
Disease control OngoingThis study tests a combination of two drugs, sacituzumab govitecan and trastuzumab, in 28 people with HER2+ breast cancer that has spread and has been previously treated. The goal is to see if this combination can shrink tumors or slow cancer growth. Participants receive both dru…
Matched conditions: HER-2 POSITIVE BREAST CANCER
Phase: PHASE2 • Sponsor: Adrienne G. Waks • Aim: Disease control
Last updated May 13, 2026 16:01 UTC